Welspun Living Limited (NSE:WELSPUNLIV)

Market Cap	112.94B
Revenue (ttm)	102.69B
Net Income (ttm)	5.41B
Shares Out	n/a
EPS (ttm)	5.67
PE Ratio	20.87
Forward PE	17.32
Dividend	1.70 (1.43%)
Ex-Dividend Date	Jun 27, 2025

Volume	2,448,448
Average Volume	3,227,096
Open	119.75
Previous Close	118.77
Day's Range	117.00 - 119.75
52-Week Range	105.00 - 213.10
Beta	-0.48
RSI	32.74
Earnings Date	Jul 25, 2025

About Revance Therapeutics

Welspun Living Limited engages in the manufacture and sale of home textile products in India and internationally. It operates through two segments, Home Textiles and Flooring. The company offers bedding solutions, including utility and fashion bedding, and bed sheet products, as well as quilts, pillows, and pillowcase sets; and spunlace, needle punch, and wet wipes. It also provides bath solutions, such as towels, bathrobes, and bathroom rugs, as well as mats, area rugs, and carpets. In addition, the company offers flooring products comprising ...

• Industry: Textile Manufacturing
• Sector: Consumer Discretionary
• Founded: 1985
• Employees: 35,000
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: WELSPUNLIV

Financial Performance

In 2024, Welspun Living's revenue was 105.45 billion, an increase of 8.95% compared to the previous year's 96.79 billion. Earnings were 6.39 billion, a decrease of -6.16%.